Navigation Links
Dr. James Hevezi Appointed as Chief Physicist for CyberKnife Center of Miami
Date:6/3/2009

MIAMI, June 3 /PRNewswire/ -- James G. Schwade, M.D., executive director of CyberKnife Center of Miami, www.cyberknifemiami.com, announced the appointment of Dr. James Hevezi as Chief Physicist for the image guided robotic radiosurgery outpatient facility.

Dr. Hevezi will oversee the technical planning and delivery for the CyberKnife patient treatment operations. An independent practitioner of medical physics, he has practiced for 35 years and is a member of the American College of Radiology Board of Chancellors and serves as Chair of the ACR Medical Physics Commission. He currently holds adjunct faculty appointments at the University of Texas Health Sciences Center at San Antonio as Professor of Radiology and Radiation Oncology.

Previously, he served as Director of Medical Physics at the Cancer Therapy and Research Center in San Antonio from 1991- 2005, where he introduced IMRT, Radiosurgical techniques and HDR and LDR Brachytherapy techniques.

Hevezi is Board Certified in Diagnostic Radiological Physics and Therapeutic Radiological Physics by the American Board of Radiology. He is a Fellow of the American College of Radiology (ACR) and the American Association of Physicists in Medicine (AAPM). He serves in leadership positions in the American Society for Therapeutic Radiology and Oncology (ASTRO) and AAPM.

CyberKnife treatment for cancer is precisely targeted image guided robotic radiosurgery that is non-invasive, painless, involves little to no side effects, and may be administered in 1-5 treatments while resuming normal physical activity immediately thereafter.

For more information regarding this and other cancer news and treatment please log on to http://www.cyberknifemiami.com'/>"/>

SOURCE CyberKnife Center of Miami
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine news :

1. James B. Hawkins Appointed to IRIDEX Board of Directors
2. James Cracknell Launches Siemens Stroke for Stroke Week
3. Marianjoy Rehabilitation Hospital to Receive James Brady Award From Brain Injury Association of Illinois
4. HealthCoach Welcomes James Herrera as Vice President of Consulting
5. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
6. Loma Linda University to Dedicate Proton Treatment Center to Cancer Therapy Pioneer James M. Slater, M.D.
7. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
8. Bobby Rush Revue and James Super Chikan Johnson Announced for Post-Race Concert
9. ATS Medical Appoints James L. Cox, M.D. as Medical Director
10. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
11. James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Thousands of DePuy Pinnacle hip lawsuits ... who were allegedly injured by a metal-on-metal version of ... in U.S. District Court, Northern District of Texas, Bernstein ... July 18, 2014, U.S. District Judge Ed Kinkeade has ... Steering Committee that sought the deposition of a witness ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July 28, ... at risk of contracting meningitis because of specific health ... updated recommendations from the largest pediatrician group in the ... potentially deadly infection should continue for adolescents and college ... its first statement on meningococcal vaccines since 2011, the ...
(Date:7/28/2014)... do not divide unless there is enough oxygen present ... other cell types circumvent this rule. Researchers at The ... overrides the cells, warning signals, enabling cancers to continue ... the process, the researchers found that lysosomes the ... decisions. They also uncovered new evidence that certain drugs ...
(Date:7/28/2014)... you,ve ordered at a restaurantor when something captures ... brain. , These waves are called gamma ... excitatory and inhibitoryplaying together in an orchestrated way. ... have been associated with higher-level brain function, and ... schizophrenia, Alzheimer,s disease, autism, epilepsy and other disorders. ...
(Date:7/28/2014)... 28, 2014 Mirena IUD lawsuits ( ... caused some users to suffer serious injuries after it ... continue to mount in U.S. courts, Bernstein Liebhard LLP ... last month in New Jersey, at least 924 Mirena ... litigation underway in Bergen County Superior Court. Some 148 ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Cell's recycling center implicated in division decisions 2Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 4
... -- Chindex International,(Nasdaq: CHDX ) today announced ... for the Ernst & Young Entrepreneur Of The ... to Ernst & Young LLP, the awards,program recognizes ... innovation, financial performance and personal commitment to,their businesses ...
... Atlas Spine, Inc., a spinal,technology development company ... today the national launch of the STATURE Vertebral ... MIS compatible spacer,system designed to utilize a self-distracting ... thoracic and lumbar spine., "After significant developmental ...
... new, highly-advanced walking robot: Flame. This type of research, for ... is important as it provides insight into how people walk. ... improved diagnoses, training and rehabilitation equipment. , If you try ... how complex an activity it is. Walking robots have been ...
... Ontario implements a ban on the retail display of ... Research Unit at the University of Toronto shows that ... point of sale. , Places where tobacco is sold ... communicate with current, former and potential smokers through large ...
... GENERATION OF SCIENTISTS, ELIZABETH, N.J., May 22 ... announced today the,establishment of the Alliance/Merck Ciencia Scholars ... higher education and,degrees in science, technology, engineering and ... $4 million grant from The Merck Company Foundation,the ...
... pioneering research with counselors June 6; provides CEUs, ... to a Ph.D. with the,last name of "Trotter," ... a horse can be more beneficial than traditional ... with other,mental health professionals during her premier Equine ...
Cached Medicine News:Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 2Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 3Health News:Atlas Spine Launches Stature(TM) Vertebral Body Replacement System 2Health News:TU Delft robot Flame walks like a human 2Health News:Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program 2Health News:Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program 3Health News:Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program 4Health News:Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program 5Health News:Equine Partners in Counseling (EPIC) Training Is Changing the Face of Mental Health 2
(Date:7/28/2014)... (NYSE: RMD ), an innovator and pioneer ... and other chronic respiratory conditions, has won a permanent ... medical device manufacturer APEX Medical Corp. (APEX), prohibiting sales ... 220 masks.  The judgment was entered by the Regional ... appealable, and applies throughout Germany.  The ...
(Date:7/28/2014)... , July 28, 2014  ANI Pharmaceuticals, Inc. (NASDAQ: ... plans to release its second quarter and year-to-date 2014 ... opening of the U.S. financial markets. The earnings press ... of the Company,s website, www.anipharmaceuticals.com . ... Officer, and Charlotte C. Arnold , Vice President ...
(Date:7/28/2014)... , July 28, 2014  ProteinSimple announced today ... the Simple Western. This new assay allows users to detect ... first time, Simple Western users can analyze proteins without ... Simple Western has changed protein analysis as we know ... Western blot protocols - no messy gels, no transfer ...
Breaking Medicine Technology:ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2ProteinSimple Says "Never Run a Gel Again!" 2
... VioQuest,Pharmaceuticals (OTC Bulletin Board: VQPH) today ... of Lenocta(TM) (sodium stibogluconate), a novel,protein tyrosine ... immune stimulant approved for the treatment of ... cancers. The open-label Phase IIa study is,designed ...
... CuraGen Corporation,(Nasdaq: CRGN ), a clinical-stage biopharmaceutical ... Exchange: TOPO) announced,today that updated preliminary clinical trial ... T-cell lymphomas, and new preclinical data,evaluating belinostat on ... 2007 American Society of Hematology (ASH) 49th Annual ...
Cached Medicine Technology:VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 2VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 3VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 4CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 2CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 3CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 4CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: